TABLE I.

Patient's Clinical Characteristics (Total N = 24)

Characteristic	Result
Age, year, median (range)	61 (41-80)
Male sex, n (%)	14 (58.3)
Race, n (%)
White	16 (66.7)
Black	6 (25)
Other	2 (8.3)
International staging system at diagnosis, n (% of 17)
I	7 (41.2)
II	5 (29.4)
III	5 (29.4)
Cytogenetics/FISH, n (% of 23)
Standard risk	12 (52.2)
High risk	11 (47.8)
Time from diagnosis to BiRd, median (range) months	36.7 (6.6-59)
Median prior therapy, n (range)	3 (1-8)
Prior stem cell transplant, n (%)	6 (25)
Prior treatment with bortezomib, n (%)	13 (54.2)
Prior treatment with thalidomide, n (%)	13 (54.2)
Prior treatment with Rd, n (%)	24 (100%)
Best response to Rd, n (%)
PR	10 (41.7)
MR	3 (12.5)
SD	7 (29.2)
PD	4 (16.7)
Median duration on Rd, mo, range	5.2 (1.6-37.8)